The Supreme Court recently concluded a busy and historic term with a number of groundbreaking and important decisions.
Continue Reading Last Month at the Supreme Court | July 2024
The Supreme Court recently concluded a busy and historic term with a number of groundbreaking and important decisions.…
Continue Reading Last Month at the Supreme Court | July 2024
On June 21, 2024, in United States v. Rahimi, the Supreme Court held that an individual found by a court to pose a credible threat to the physical safety of another may be temporarily disarmed consistent with the Second Amendment. Chief Justice Roberts authored the opinion for the Court. Several Justices wrote concurring opinions. Justice Thomas was the lone dissenter.…
On June 27, 2024, the Supreme Court held in SEC v. Jarkesy that Congress violated the Seventh Amendment by allowing the Securities and Exchange Commission to pursue civil penalties through administrative proceedings that do not allow defendants to be tried by a jury. Chief Justice Roberts authored the opinion. Justice Gorsuch filed a concurring opinion, joined by Justice Thomas. Justice Sotomayor authored the dissent, joined by Justices Kagan and Jackson.…
On June 20, 2024, in Moore v. United States, the Supreme Court held that the Mandatory Repatriation Tax (MRT), a corporate tax on foreign earnings, is constitutional under the Sixteenth Amendment. Justice Kavanaugh authored the opinion for the Court. Justice Jackson wrote a concurring opinion. Justice Barrett filed an opinion concurring in the judgment, joined by Justice Alito. Justice Thomas authored a dissenting opinion, joined by Justice Gorsuch.…
Continue Reading Decision Alert: Supreme Court Upholds Mandatory Repatriation Tax
On June 21, 2024, in Erlinger v. United States, the Supreme Court held that the Fifth and Sixth Amendments require a jury to unanimously find beyond a reasonable doubt that a defendant’s previous offenses qualify for purposes of enhancement under the Armed Career Criminal Act (ACCA), 18 U.S.C. § 924(e). Justice Gorsuch delivered the opinion of the Court. Chief Justice Roberts wrote a concurring opinion. Justices Kavanaugh and Jackson wrote dissenting opinions.…
On June 20, 2024, the Supreme Court held (6-3) in Chiaverini v. City of Napoleon, Ohio that a plaintiff charged with a crime not supported by probable cause can prevail on a Fourth Amendment malicious prosecution claim under 42 U.S.C. § 1983 even if he is charged with other crimes that are supported by probable cause. Justice Kagan delivered the majority opinion for the Court, vacating the Sixth Circuit’s decision and remanding the case.…
On June 21, 2024, in Smith v. Arizona, the Supreme Court unanimously held that when an expert conveys an absent lab analyst’s statements in support of the expert’s opinion, and the statements provide that support only if true, then the statements come into evidence for their truth. Consequently, they implicate the Sixth Amendment’s Confrontation Clause. Justice Kagan delivered the majority opinion for the Court, vacating the Arizona Court of Appeals’ decision and remanding the case.…
On June 28, 2024, the Supreme Court delivered a landmark ruling in Loper Bright Enterprises, Inc. v. Raimondo, Sec. of Commerce, et al., overruling Chevron. This decision will have far-reaching implications for virtually every regulated industry, with potentially seismic impacts for businesses subject to environmental, climate, transportation, manufacturing, healthcare, securities, and energy regulation.…
On June 13, 2024, in Vidal v. Elster, the Supreme Court unanimously held that the Lanham Act’s restriction of trademarks based on a living person’s name does not violate the First Amendment. The case marks the first time the Court has held that a solely content-based restriction on trademark registration need not be evaluated under heightened scrutiny. Even though the decision was unanimous, the justices’ reasoning was not.…
Last week, the Supreme Court continued to issue significant rulings. These include unanimously holding that abortion medication objectors lack standing to challenge FDA decisions related to the use of the medication, striking down ATF’s classification of “bump stocks” as machineguns, and unanimously upholding the USPTO’s refusal to register a “TRUMP TOO SMALL” trademark. The following decision alerts offer analysis and practical takeaways. Click the links below to read more about each decision.…
We use cookies on our site to give you the best possible online experience. If you do not want to receive cookies, you can change your cookie settings. By using the site, you are providing consent to receive cookies. For more information, view our Privacy Policy.